Pediatric Death After Withdrawal of Life-Sustaining Therapies: A Scoping Review

Conall Francoeur1, Amina Silva2, Laura Hornby3

  • 1Division of Pediatric Critical Care, Department of Pediatrics, McGill University, Montreal, QC, Canada.

Insights

The dying process in children after withdrawal of life-sustaining measures (WLSM) is poorly understood. Improving time to death prediction after WLSM can enhance care and support for families and healthcare teams.

Area of Science:

  • Pediatric critical care medicine
  • Palliative and end-of-life care
  • Bioethics

Background:

  • The dying process in children following withdrawal of life-sustaining measures (WLSM) in the pediatric intensive care unit (PICU) is complex and understudied.
  • Existing literature lacks comprehensive understanding of the physiological aspects, prediction of time to death, and the profound impact on families and healthcare professionals.

Purpose of the Study:

  • To systematically evaluate the existing literature on the dying process in children after WLSM in the PICU.
  • To explore the physiology of dying, predictability of time to death, and the psychological impact on families and healthcare workers.
  • To identify implications for organ donation and future research priorities.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (MEDLINE, Embase, Cochrane, PsycINFO, CINAHL, Web of Science).
  • Studies focusing on the dying process after WLSM in the PICU were included, with no restrictions on date or study type.
  • Inductive qualitative content analysis was employed to synthesize findings from the 24 included studies.

Main Results:

  • Few validated tools exist for predicting time to death after WLSM in children; most deaths occur within one hour.
  • The unpredictability of the dying process creates significant emotional challenges and stress for families and healthcare providers.
  • Uncertainty surrounding the timing of death negatively impacts families' likelihood of considering organ donation.

Conclusions:

  • The dying process in pediatric critical care is inadequately understood, leaving families and clinical teams without sufficient support tools.
  • Enhancing the prediction of time to death following WLSM is crucial for improving end-of-life care provision.
  • Improved understanding and prediction can facilitate better support for patients, families, and healthcare professionals, and potentially increase organ donor identification.
Abstract

Related Concept Videos

Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
1.0K
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
78
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
1.1K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
17